Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
Indion 190 Resin Catalyzed Environmentally Benign Protocol for Synthesis of an Anticancer Drug Enzalutamide
Author(s): Sampat Yewale*, YS MalgheAn environmentally benign and economically viable protocol has been developed for the synthesis of the anticancer drug Enzalutamide using Indion 190 resin. Ambient condition, short reaction time, simple work-up procedure, high yield, easily available and reusable heterogeneous Indion 190 catalyst, are some of the striking features of the present method. Enzalutamide is known as 4-{3-[4-cyano-3-(trif1uoromethy1) pheny1]-5,5-dimethy1-4-oxo-2-su1fanylide-neimidazolidin-1-yl}-2-f1uoro-N-methy1benzamide. Enzalutamide is an androgen receptor inhibitor that acts on different steps in the androgen receptor signaling pathway. Enzalutamide has been shown to competitively inhibit androgen binding to androgen receptors and inhibit androgen receptor nuclear translocation and interaction with DNA
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 25868
Der Pharma Chemica received 25868 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
DOWNLOADS
